Vasir Jaspreet K, Labhasetwar Vinod
Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.
Adv Drug Deliv Rev. 2007 Aug 10;59(8):718-28. doi: 10.1016/j.addr.2007.06.003. Epub 2007 Jun 26.
Many therapeutics require efficient cytosolic delivery either because the receptors for those drugs are located in the cytosol or their site of action is an intracellular organelle that requires transport through the cytosolic compartment. To achieve efficient cytosolic delivery of therapeutics, different nanomaterials have been developed that consider the diverse physicochemical nature of therapeutics (macromolecule to small molecule; water soluble to water insoluble) and various membrane associated and intracellular barriers that these systems need to overcome to efficiently deliver and retain therapeutics in the cytoplasmic compartment. Our interest is in investigating PLGA and PLA-based nanoparticles for intracellular delivery of drugs and genes. The present review discusses the various aspects of our studies and emphasizes the need for understanding of the molecular mechanisms of intracellular trafficking of nanoparticles in order to develop an efficient cytosolic delivery system.
许多治疗药物都需要高效的胞质递送,这要么是因为这些药物的受体位于胞质溶胶中,要么是因为它们的作用位点是一个细胞内细胞器,需要通过胞质区室进行转运。为了实现治疗药物的高效胞质递送,人们开发了不同的纳米材料,这些材料考虑了治疗药物多样的物理化学性质(从大分子到小分子;从水溶性到水不溶性)以及这些系统为了在细胞质区室中有效递送和保留治疗药物而需要克服的各种与膜相关的和细胞内的障碍。我们感兴趣的是研究基于聚乳酸-羟基乙酸共聚物(PLGA)和聚乳酸(PLA)的纳米颗粒用于药物和基因的细胞内递送。本综述讨论了我们研究的各个方面,并强调了为开发高效的胞质递送系统而了解纳米颗粒细胞内运输分子机制的必要性。
Adv Drug Deliv Rev. 2007-8-10
J Mater Sci Mater Med. 2006-6
Pharm Res. 2000-10
Adv Drug Deliv Rev. 2003-2-24
Int J Nanomedicine. 2013-2-21
Antibiotics (Basel). 2024-3-28
Front Bioeng Biotechnol. 2024-3-20
Drug Deliv Transl Res. 2024-10
ACS Biomater Sci Eng. 2024-3-11
J Neurol Sci. 2006-5-15
J Control Release. 2006-5-15
Curr Drug Deliv. 2004-7
J Control Release. 2005-12-5
Gene Ther. 2005-10